Successful treatment of immune checkpoint inhibitor-related periaortitis

Swiss Med Wkly. 2024 Feb 15:154:3631. doi: 10.57187/s.3631.

Abstract

We report a 64-year-old patient with melanoma receiving ipilimumab and nivolumab therapy who presented with a periaortic soft tissue mass around the abdominal aorta on restaging fluorodeoxyglucose positron emission tomography/computed tomography imaging. Clinical, laboratory, and radiologic findings resulted in a diagnosis of immune checkpoint inhibitor-related periaortitis. Periaortitis is a rare disease presenting with fibro-inflammatory tissue around the aorta and may lead to serious complications. Immune checkpoint inhibitors were discontinued, and the patient was treated with glucocorticoids, leading to a complete resolution of the periaortitis. To our knowledge, this is only the third reported case of immune checkpoint inhibitor-related periaortitis.

Publication types

  • Case Reports

MeSH terms

  • Glucocorticoids / therapeutic use
  • Humans
  • Immune Checkpoint Inhibitors* / adverse effects
  • Ipilimumab / adverse effects
  • Melanoma* / drug therapy
  • Middle Aged
  • Nivolumab / adverse effects
  • Positron Emission Tomography Computed Tomography

Substances

  • Immune Checkpoint Inhibitors
  • Nivolumab
  • Glucocorticoids
  • Ipilimumab